Fig. 4From: The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyAssociation between pCR rate and DTC-eradication. Bar chart showing pCR rate after NACT ± denosumab among the total cohort and the different subtypes of breast cancer with regard to DTC-eradication. P values according to the Fisher's Exact Test are indicated. HR: hormone receptor; HER2: human epidermal growth receptor 2; TNBC: triple-negative breast cancerBack to article page